Conditions

close

result 19474 件

JaLCDOI 10.18926/AMO/46630
FullText URL 65_3_185.pdf
Author Watanabe, Kumi| Okada, Ayumi| Okabe, Nobuyuki| Onishi, Masaru| Morishima, Tsuneo|
Abstract The purpose of this study was to investigate the psychological needs of children and adolescents with eating disorders (ED) directed toward their mothers. Patients with ED have low self-assertion and various abnormal eating behaviors. Therefore, mothers face difficulty in understanding their children's psychological needs, and the mother-child relationship is sometimes strained. We developed a One-Message Question (OMQ)-structured interview. The OMQ was easy to answer, and it helped the patients with ED. We examined the relationship between psychological needs and illness phase of the children and adolescents, and we discuss the viability of implementing the OMQ in clinical settings. The subjects were 23 patients and their parents. Their parents were just asked about the patients' background. The mean age of the patients was 15.8 years, and the average age of ED onset was 13.5 years. The EDs were anorexia nervosa (n=20) and bulimia nervosa (n=3). The phases of patients' illness were identified as anorexic (n=5), bulimic (n=7), chronic (n=3), and stable (n=8). All subjects provided specific responses to the OMQ-structured interview. Data analyses revealed the following seven categories of patients' psychological needs directed toward their mothers:attachment, cooperation in meeting their goals, longing for love, changing attitude toward family members, respect for self-reliance, expression of apology, and expression of appreciation. These findings suggested that the OMQ-structured interview may prove useful for mothers to understand their children's psychological needs and may encourage positive interactions as a foundation for future recovery.
Keywords family support mother-child relationships eating disorders in children and adolescents interview methods team approach
Amo Type Original Article
Publication Title Acta Medica Okayama
Published Date 2011-06
Volume volume65
Issue issue3
Publisher Okayama University Medical School
Start Page 185
End Page 192
ISSN 0386-300X
NCID AA00508441
Content Type Journal Article
language English
Copyright Holders CopyrightⒸ 2011 by Okayama University Medical School
File Version publisher
Refereed True
PubMed ID 21709716
Web of Science KeyUT 000292017500005
JaLCDOI 10.18926/AMO/46628
FullText URL 65_3_169.pdf
Author Takeda, Masanori| Nagasaka, Takeshi| Dong-Sheng, Sun| Nishie, Hiroyuki| Oka, Tetsuhiro| Yamada, Eiji| Mori, Yoshiko| Shigeyasu, Kunitoshi| Morikawa, Tatsuya| Mizobuchi, Satoshi| Fujiwara, Toshiyoshi|
Abstract Secreted frizzled-related protein 2, (SFRP2) is a Wnt inhibitor whose promoter CpGs were recently found to be methylated at high frequency in colorectal cancers (CRCs). We hypothesized that the pattern of SFRP2 methylation may differ throughout the promoter during progressive tumorigenesis. Using combined bisulfite restriction analysis (COBRA), two methylation-sensitive regions (Regions A and B) of the SFRP2 promoter were investigated in 569 specimens of colorectal tissue:222 CRCs, 103 adenomatous polyps (APs), 208 normal colonic mucosa from CRC patients (N-Cs), and 36 normal colonic mucosa from subjects with no evidence of colorectal neoplasia at colonoscopy (N-Ns). Extensive (including both Regions A and B) and partial (either Region A or B) SFRP2 methylation levels were found in 61.7% and 24.8% of CRCs, 8.7% and 37.9% of APs, 3.9% and 39.9% of N-Cs, and 0% and 30.6% of N-Ns, respectively. Extensive methylation of the SFRP2 promoter was present primarily in CRCs, while partial methylation was common in APs. Whereas APs with the KRAS mutant showed no correlation to any pattern of SFRP2 methylation, extensive methylation of the SFRP2 promoter was significantly associated with KRAS mutant CRCs (p<.0001), suggesting that genetic alteration in the RAS-RAF pathway might precede the spread of CpG methylation through the SFRP2 promoter, which is observed in over 60% of advanced colorectal tumors.
Keywords BRAF/KRAS mutations promoter methylation colorectal cancer
Amo Type Original Article
Publication Title Acta Medica Okayama
Published Date 2011-06
Volume volume65
Issue issue3
Publisher Okayama University Medical School
Start Page 169
End Page 177
ISSN 0386-300X
NCID AA00508441
Content Type Journal Article
language English
Copyright Holders CopyrightⒸ 2011 by Okayama University Medical School
File Version publisher
Refereed True
PubMed ID 21709714
Web of Science KeyUT 000292017500003
JaLCDOI 10.18926/AMO/46626
FullText URL 65_3_151.pdf
Author Fujiwara, Toshiyoshi|
Abstract Replication-selective tumor-specific viruses constitute a novel approach for treatment of neoplastic disease. These vectors are designed to induce virus-mediated lysis of tumor cells after selective viral propagation within the tumor. Human telomerase is highly active in more than 85オ of primary cancers, regardless of their tissue origins, and its activity correlates closely with human telomerase reverse transcriptase (hTERT) expression. We constructed an attenuated adenovirus 5 vector (Telomelysin, OBP-301), in which the hTERT promoter element drives expression of E1 genes. Since only tumor cells that express telomerase activity would activate this promoter, the hTERT proximal promoter would allow for preferential expression of viral genes in tumor cells, leading to selective viral replication and oncolytic cell death. Lymphatic invasion is a major route for cancer cell dissemination, and adequate treatment of locoregional lymph nodes is required for curative treatment in patients with gastrointestinal tumors. We demonstrated that intratumoral injection of Telomelysin mediates effective in vivo purging of metastatic tumor cells from regional lymph nodes. Moreover, using noninvasive whole-body imaging, we found that intratumoral injection of Telomelysin followed by regional irradiation induces a substantial antitumor effect, resulting from tumor cell-specific radiosensitization, in an orthotopic human esophageal cancer xenograft model. These results illustrate the potential of oncolytic virotherapy as a promising strategy in the management of human gastrointestinal cancer.
Keywords telomerase adenovirus metastasis lymph node colorectal cancer
Amo Type Review
Publication Title Acta Medica Okayama
Published Date 2011-06
Volume volume65
Issue issue3
Publisher Okayama University Medical School
Start Page 151
End Page 162
ISSN 0386-300X
NCID AA00508441
Content Type Journal Article
language English
Copyright Holders CopyrightⒸ 2011 by Okayama University Medical School
File Version publisher
Refereed True
PubMed ID 21709712
Web of Science KeyUT 000292017500001
Author Sigenoi, Siko|
Published Date 1929-07-31
Publication Title 岡山医学会雑誌
Volume volume41
Issue issue7
Content Type Journal Article
Author Takahashi, Shozo|
Published Date 1929-07-31
Publication Title 岡山医学会雑誌
Volume volume41
Issue issue7
Content Type Journal Article
Author Nakamura, Eri|
Published Date 2011-03-25
Publication Title
Content Type Thesis or Dissertation
Author Kikuchi, Yoichiro|
Published Date 2011-03-25
Publication Title
Content Type Thesis or Dissertation
Author Shiozawa, Nobuyoshi|
Published Date 2011-03-25
Publication Title
Content Type Thesis or Dissertation
Author Iwase, Toshihide|
Published Date 2011-03-25
Publication Title
Content Type Thesis or Dissertation
Author Huang, Xingang|
Published Date 2011-03-25
Publication Title
Content Type Thesis or Dissertation
Author Kajitani, Nobuo|
Published Date 2011-03-25
Publication Title
Content Type Thesis or Dissertation
Author Wakimoto, Mari|
Published Date 2011-03-25
Publication Title
Content Type Thesis or Dissertation
Author Kumada, Ai|
Published Date 2011-03-25
Publication Title
Content Type Thesis or Dissertation
Author Sasaki, Motofumi|
Published Date 2011-03-25
Publication Title
Content Type Thesis or Dissertation
Author Tsuzuki, Takao|
Published Date 2011-03-25
Publication Title
Content Type Thesis or Dissertation
Author Adachi, Hideyuki|
Published Date 2011-03-25
Publication Title
Content Type Thesis or Dissertation